INTRODUCTION Chronic kidney disease (CKD) infers directly in functional capacity, independence and therefore quality of life (QOL). OBJECTIVE To compare the physical fitness and quality of life of patients with chronic kidney disease submitted on hemodialysis (G1) and predialysis treatment (G2). METHODS A cross-sectional study, 54 patients with CKD, 27 of the G1 group (58.15 ± 10.84 years),...

Abstract Background and Aims Timely arteriovenous (AV) access creation in view of starting hemodialysis is challenged by non-linear kidney function decline the prospect competing mortality. In addition, some studies have shown slower CKD progression following AV patients not on dialysis. While pathophysiological mechanisms, such as ischemic preconditioning improved perfusion, been put forward t...

Chronic Kidney Disease (CKD) is becoming one of the major public health problems. Incidence of CKD is doubled in last fifteen years. CKD is under diagnosed and undertreated. The treatment cost is high and outcome is poor. In India, only 10% of patients with end stage renal disease (ESRD) have access to renal replacement therapy. Therefore action plan should be early detection of CKD by screenin...

Bisphenol A (BPA), a component of some dialysis membranes, accumulates in CKD. Observational studies have linked BPA exposure to kidney and cardiovascular injury in humans, and animal studies have described a causative link. Normal kidneys rapidly excrete BPA, but insufficient excretion may sensitize patients with CKD to adverse the effects of BPA. Using a crossover design, we studied the effec...

Patients with chronic kidney disease (CKD) have higher rates of fracture than the general population. Increased bone remodeling, leading to microarchitectural deterioration and increased fragility, may accompany declining kidney function, but there are no reliable methods to identify patients at increased risk for fracture. In this cross-sectional study of 82 patients with predialysis CKD, high...

OBJECTIVES The main question of this study was to evaluate the intensity of oxidative protein modification shown as advanced oxidation protein products (AOPP) and carbonylated proteins, expressed as protein carbonyl content (C=O) in abdominal aortic aneurysms (AAA), aortoiliac occlusive disease (AIOD), and chronic kidney disease (CKD). DESIGN AND METHODS The study was carried out in a group o...

Purpose. To explore factors contributing to chronic kidney disease (CKD) progression and change in estimated glomerular filtration rate over time (ΔeGFR) as a risk factor in predialysis patients under multidisciplinary managements. Methods. Among 113 CKD patients, eGFR, serum creatinine, total protein, albumin, urea nitrogen, uric acid, calcium, inorganic phosphate, total cholesterol, urinary c...

Paricalcitol is approved for prevention and therapy of secondary hyperparathyroidism (sHPT) in patients with chronic kidney disease (CKD), with only short-term data in clinical routine settings. A 12-month observational study was conducted in Germany and Austria (90 centers, 761 patients) from 2008 to 2013. Laboratory values, demographical, and clinical data were documented in 629 dialysis pati...

BACKGROUND Coronary artery disease and left ventricular hypertrophy are prevalent in the chronic kidney disease (CKD) and renal transplant (RT) population. Advances in cardiovascular magnetic resonance (CMR) with blood oxygen level-dependent (BOLD) technique provides capability to assess myocardial oxygenation as a measure of ischemia. We hypothesized that the myocardial oxygenation response to...